Stock A028300 HLB CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

All News HLB Co., Ltd.

Equities

A028300

KR7028300002

End-of-day quote Korea S.E.
Other stock markets
 18:00:00 2024-06-30 EDT 		5-day change 1st Jan Change
62,600 KRW +7.01% Intraday chart for HLB Co., Ltd. -5.15% +23.47%
05-14 HLB Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-01 HLB Therapeutics Co.,Ltd. announced that it has received KRW 29.99999658 billion in funding from HLB Co., Ltd. CI

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
HLB Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
HLB Therapeutics Co.,Ltd. announced that it has received KRW 29.99999658 billion in funding from HLB Co., Ltd.
CI
HLB Life Science to Raise 148.5 Billion Won via Shares Issuance; Shares Decline 8%
MT
HLB Therapeutics Co.,Ltd. announced that it expects to receive KRW 29.99999658 billion in funding from HLB Co., Ltd. and other investors
CI
HLB Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
HLB Co., Ltd. announced that it has received KRW 60 billion in funding from a group of investors
CI
HLB Co., Ltd. announced that it expects to receive KRW 60 billion in funding from a group of investors
CI
Bank of Canada Holds Rates Steady; ECB Expected -2-
DJ
South Korean Shares Marginally Decline for Second Day on Profit-Booking
MT
HLB Shareholders Endorse Transition to Main Bourse from KOSDAQ
MT
BPH Energy Appoints HLB Mann Judd as Auditor; Shares Plunge 10%
MT
Century Sunshine Group’s Auditor Resigns; Successor Named
MT
Rare Earth Magnesium’s Auditor Steps Down; Successor Appointed
MT
Jinhai International Gets New Auditor
MT
HLB Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
HLB, Hong Leong Islamic Bank, Cagamas Conclude MYR300 Million Green Assests Deal
MT
Spenda Halts Trade Pending Court Nod for Auditor Appointment
MT
5E Resources Appoints New Auditors
MT
Elevar Therapeutics, Inc. announced that it has received KRW 58.174676146 billion in funding from HLB Co., Ltd.
CI
Elevar Therapeutics, Inc. announced that it expects to receive KRW 58.174676146 billion in funding from HLB Co., Ltd.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. A028300 Stock
  4. News HLB Co., Ltd.